According to the guidelines for the treatment of HF, beta-blockers and ACE inhibitors are indicated in patients with reduced LVEF, but the cardioprotective role of these drugs in preventing or mitigating ICI-related myocarditis has not yet been demonstrated [1,25]. This evidence concerns the gene ACE and myocarditis.